We are thrilled to announce that the FDA has granted us our second Breakthrough Device Designation. This designation is specifically for the application of our SakuraBead technology in treating Adhesive Capsulitis.

Commonly referred to as Frozen Shoulder, it is a condition characterized by stiffness and pain in the shoulder joint. It occurs when the connective tissue surrounding the shoulder joint, known as the shoulder capsule, becomes inflamed and thickened.

This recognition underscores the increasing promise of Musculoskeletal Embolisation in addressing various chronic pain conditions.